HT
Hale has developed a digital drug therapy device that automatically adjusts nicotine intake over time, utilizing a patent-pending design to facilitate gradual de-addiction. This connected device, paired with a mobile app for usage tracking, addresses the challenge of nicotine addiction by providing a low-risk alternative to traditional cessation methods.
Updated 4 months ago
Funding
$2.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Hale has developed a digital drug therapy device that automatically adjusts nicotine intake over time, utilizing a patent-pending design to facilitate gradual de-addiction. This connected device, paired with a mobile app for usage tracking, addresses the challenge of nicotine addiction by providing a low-risk alternative to traditional cessation methods.